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Summary.-The effects of local tumour radiation over the dose range 7-5-30 Gy on
the growth and cell kinetics of rat hepatoma H-4-II-E have been investigated. A plot
of growth delays against log surviving fraction was linear below a fraction of 0*03,
but failed to extrapolate to the origin. Following a single dose of 15 Gy to the tumour,
DNA-precursor incorporation, labelling and mitotic indices were depressed for 7
days. Tumour cellularity, measured as DNA/g tumour, was reduced and the rate of
increase of total clonogenic cells slower than after complete tumour recovery. From
Day 7 to Day 9 all indices of proliferation recovered to about control levels, clonogenic
cell numbers increased more rapidly and tumour cellularity was restored. Repopula-
tion of the tumour therefore appeared to take place mainly after Day7. Incorporation
of [3H]-TdR into tumour DNA reached twice the control values on Day 9. The rate of
tumour growth accelerated after the initial decrease, and maximum tumour growth
rate was also twice the control values on Day 13. Accelerated growth rates inirradiated
tumours, above those of control tumours, occurred 10-16 days after treatment. The
effectiveness of sequential therapy may therefore be improved if given during this
period of accelerated tumour growth.
THE KINETICS of tumour cell population
recovery following X-irradiation are not
well known, thus, the factors governing
the timing of tumour recovery are even
less well understood. This lack of know-
ledge results in part from the following
factors: too few studies have documented
both tumour volume and tumour cell
kinetic changes simultaneouslv (Barendsen
& Broerse, 1969 and Hermens, 1973, are
notable exceptions), the results of such
investigations may be confused by repair
phenomena (Twentyman & Bleehen, 1975)
or host factors (Janik & Steel, 1972), and
the validity of assays necessary for deter-
mining tumour cell population changes, in
particular the clonogenic assay, is un-
certain (McNally, 1973).
In an attempt to overcome some of
these difficulties, we have examined the
effects of single doses of radiation upon a
hepatoma, grown s.c., combining assays
for volume, cell kinetic, cell survival and
biochemical changes. The tumour line,
H-4-IJ-E, is derived from the Reuber
hepatoma H-35 (Evans & Kovacs, 1977).
It readily metastasizes to the lungs and
regional lymph nodes and is resistant to
radiation and three types of chemo-
therapeutic agent (adriamycin, cyclo-
phosphamide and 5-fluorouracil). H-4-II-E
is thus a realistic tumour model.
MATERIALS AND METHODS
Animalsq and tumours
Hepatoma H-4-II-E cells, obtained origin-
ally from Dr V. R. Potter, University of
Wisconsin, were maintained in vitro in
Swim's 77 medium with 25% serum (20%
horse, 5% foetal bovine, GIBCO, New York).
Cells were passed weekly on attaining con-KINETICS OF AN IRRADIATED TUMOUR
fluence. In vitro growth characteristics are
detailed in Kovacs et al. (1977).
S.c. inoculation of 2 x 106 log-phase cells
in 0-1 ml serum-free medium into the flank
of male ACI rats (Laboratory Supply Com-
pany, Indianapolis, IN) produced palpable
tumours in 7 to 9 days. Rat weight at inocula-
tion was 120-140 g. Animals were caged
individually in an air-conditioned room,
lighted from 08:00 to 20:00, with rat chow
(Charles River Laboratories, Wilmington,
MA) and water ad libitum.
Irradiation
X-rays were produced by a General Electric
Maximar III 250 (250 kV, 15 mA; filtered
with 0-25mm Cu and I 0mm Al). Before
irradiation, animals were anaesthetized with
etherandplacedinalead-shieldedboxthrough
which the tumour protruded. The midpoint
ofthe tumour was 6 cm from the X-ray-tube
target and received the doses indicated, while
the animal body received 0-5% of that dose.
X-ray output was routinely calibrated with a
Victoreen R-meter. Radiation doses are given
here as the machine output in grays (Gy).
Dose rate was 2-6 Gy/min.
Tumour assays
Volume.-Tumour volumes were calcu-
lated from the length, width and height, on
the assumption that tumours are hemi-
ellipsoids, in which volume= 1/2 [4/3 IT L/2.
W/2.H], which reduces to LWH/2. Measure-
ments were made daily. Treatments were
given when volumes first exceeded 200 mm3
for volume regrowth experiments, or when in
excess of 700 mm3 for clonogenicity and
biochemical assays. Volume responses to
radiation at these 2 tumour sizes were similar.
Tumour-volume growth curves were fitted
by the method of least squares with a poly-
nomial ofdegree 3-6.
Tumour volumes are normalized to the
volume on day of treatment and plotted on a
semilog scale for each animal. The result is a
series of graphs of In (Vt/Vo) vs time where
Vt is the tumour volume at time t and Vo
is the volume at treatment. These tumour-
volume growth curves are then fitted by the
method of least squares with a polynomial of
degree N the functional form of which is
In (t)=ao+alt+a2t2+ ... aNtN
where N values of up to 6 are necessary for a
proper fit. Instantaneous tumour growth rate
at any time can then be determined by taking
the first derivative of the polynomial with
respect to time (Looney et al., 1980b).
Growth delays were determined as the
difference between the time for treated and
control tumours to grow from the volume at
treatment (Vo) to 8 x Vo. Time to reach the
endpoint volume was calculated for each
tumour and the results averaged. Standard
errors for growth delay were calculated by the
formula AD= V/AC2+ AT2 where AD is the
standard error for growth delay, AC=the
standard error of the mean time for controls
to reach the endpoint volume, and AT=the
standard error of the mean time for treated
tumours to reach endpoint volume.
Clonogenicity.-Tumours were resected
from rats killed with ether, weighed and
minced with scalpels. The tumour mince was
suspended in 37°C buffered trypsin (activity
1:250, DIFCO) at 1 g/30 ml. The mix was
stirred for 15 min, filtered through gauze,
and diluted with an equal volume of serum
medium. Cell numbers were counted by
haemacytometer using Crystal Violet stain.
Cells were plated into 10cm-diameter plastic
Petri dishes. The number ofclones containing
more than 50 cells was scored after 10 days'
incubation, and the proportion of clone-
forming cells in treated tumour-cell suspen-
sions expressed as a fraction of that for un-
treated control tumours.
DNA content and specific activity.-One
hour before being killed rats were given
50 ,tCi i.p. of 3H-(methyl)-thymidine (sp.
act. 3 Ci/mM). DNA was extracted from a
sample oftumour by procedures described by
Hopkins et al. (1976), and DNA content/g
tumour measured according to Burton (1956).
Calf thymus DNA was the standard. Radio-
activity in the nucleic acid extracts was
measured on a Beckman liquid-scintillation
spectrophotometer with external standardiza-
tion.
Lightmicroscopyoftissuesections.-Tumour
tissue specimens were fixed in neutral for-
malin, embedded in paraffin, sectioned and
stained by the Feulgen reaction. Slides were
dipped in Kodak NTB 2 photographic emul-
sion for autoradiography, exposed for 3-5
weeks, and developed in Kodak D-19. The
percentage of nuclei bearing >3 silver grains
was scored from random traverses of the
section.
Histological evaluation was performed on
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haematoxylin-eosin stained slides of tumour
portions 0-6-1V6 cm in diameter. Only those
areas of tumour which appeared morpho-
logically viable were evaluated (i.e., areas
with cytoplasmic haematoxylinophilia). Veins
measuring 50-100 ,um were used as focal
points and all surrounding perivascular tissue
within a 1mm radius was examined. Two foci
per tumour were evaluated for identification
of mitoses. Only obvious mitoses were
counted (e.g., metaphase, anaphase, and
telophase stages with clearly identifiable
chromosomes) (Fig 1lA). No examined field
contained necrotic tissue. Forty-eight rat
tumours were examined histologically.
All slides were evaluated for degree of
necrosis, amount of haemorrhage, degree of
capsular lymphocytic infiltrates and lympho-
cytic infiltration of tumour. Nuclear dia-
meters, as well as total cell diameters, were
measured with a Zeiss Kpl-WlOX ocular
micrometer.
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FIG. 1B.-Changes in tumour growth rate
after 15Gy. 0, mean of the instantaneous
growth rates for 8 H-4-II-E tumours on the
indicated day after treatment; 0, controls;
bars, +s.e. Length ofthe period ofaccelera-
ted growth rate (8-3 days) was determined
as the full width at half maximum peak
height.
RESULTS
An effect upon tumour growth was seen
{ by Day 2 after irradiation at all doses
(Fig. 1A). Below 15 Gy growth was
slowed; exposures of 20 or 30 Gy caused
regression. In all instances the treated-
tumour growth rates ultimately returned
to control levels. Growth rate fell below
the control level the first week4fter 15 Gy.
It then accelerated and growth rates com-
parable to controls were achieved by
Day 10 (Fig. 1B). Maximum tumour
growth rates after radiation occurred on
i Day 13.
The log surviving fraction of cells
irradiated in vivo and immediately
assayed for cloning ability in vitro de-
creased exponentially with dose (Do= 4 11
Gy) and without a significant shoulder
(n= 1.31). The plating efficiency (PE) of
controls in this experiment was 0*26
r (Fig. 2). The relationship between log
surviving fraction and growth delay at
l0Z
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FiG. 2.-In vitro cloning ability according
to tumour dose of X-irradiation in situ.
Each point is the mean surviving fraction
of 3 tumours, relative to the control (10).
Vertical bars represent, + s.e.
equivalent doses is biphasic (Fig. 3).
Below 0*03 surviving fraction (15 Gy) the
points fit a straight line with a correlation
coefficient of 0 967. This curve diverges
from the theoretical curve (broken line)
that denotes the expected time for a
population oftumour cells with a doubling
time of 49-2 h (the doubling time of the
untreated tumour; Evans & Kovacs, 1977)
to return to its pretreatment size.
Clonogenic assays made at intervals
after 15 Gy X-rays (Fig. 4) showed that
the clonogenic fraction increased ex-
ponentially from 0 03 on Day 0 to 1 0 on
Day 9 or 10 (control PE=0 32). This
assay requires the enzymic dissociation of
the tumour to a single-cell suspension.
The cell yield (cells/g untreated tumour)
(Fig. 5) was 2-5 x 107 (excluding lympho-
cytes but not other host cells) and did not
show a dependent variation with tumour
weight over the range used in these experi-
ments. Yields were reduced from Day 1 to
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FIG. 3. Tumour growth delays (mean of 4
experiments) plotted against surviving frac-
tion assayed in vitro 1 h after X-irradiation
in vivo.
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FIG. 4. Changes in the in vitro clonogenic
fraction of H-4-II-E tumours at intervals
after 15Gy X-rays. Each point is the mean
for 3 tumours when s.e. bars are included,
or 2 when absent. The 2 straight-line por-
tions of the curve were fitted separately by
regression analysis.
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ling time, Td=2*3 days), Days 7-9 cell
numbers increased 20-fold (Td = 046 days
or 11-2 h) and Day 9 onwards Td=4-5
days. Evans & Kovacs (1977) reported, for
0
E
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FIG. 5. Cell yields per tumour dissociated c
for clonogenic assay, at intervals after E
irradiating the tumour with iSGy X-rays.
The solid point (0) is the mean for 10
untreated tumours. Open symbols (0)
represent the means for 3 treated tumours
(the first is h after irradiation). Vertical
lines indicate +s.e. The curve was fitted
by eye.
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FIG. 7.-Changes in DNA content of
H-4-II-E tumours (mg DNA/g tumour)
after l5Gy X-rays. Each point is the mean
of 3 tumours where there is an s.e. bar,
2 where no bar. *, untreated; 0, 15 Gy.
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FiG. 6.-Total numbers ofclonogeniccellsafter
iSGy X-rays. Values were determined per
tumour. 3 tumours were sampled per point
where s.e. bars are included, 2 where absent.
Day 7 after 15 Gy. Total clonogenic cells
per tumour (the product oftumour weight
at resection, cell yield and clonogenic
fraction for individual tumours) increased
in 3 phases after irradiation (Fig. 6): Days
0-7 cell numbers increased 10-fold (doub-
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Fia. 8.-DNA labelling with time from
irradiation. Tumours were sampled 1 h after
[3H]-TdR administration to the animal.
Points are means of 3 tumours + s.e. 0,
untreated; 0, 15 Gy.
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TABLE.-Percentages of abnormal mitoses
and nuclear diameters at intervals after
15 Gy X-rays to the tumour in situ
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FIG. 9. Changes in the percen
labelled cells in tumours sampled,
vals after irradiation. Tritiated th
was administered to the animal 1
killing. 0, untreated; 0, 15 Gy.
untreated tumours, volume Td
and in vivo cell cycle time of 36
DNA/mg of untreated tumoui
with tumour volume (Fig. 7)
because larger tumours cont
blood. After 15 Gy, DNA/mg c
a nadir on Day 7 and then re
above controls. The specific a
[3H]-TdR in these DNA samp]
similar kinetics, the recovery p
ing at twice the control activit
Labelling and mitotic indic
and 10 respectively) initially de
irradiation (15 Gy) also rec
Day 7. Mitoses were always mc
16- 214
12- 210
` 6 - T
Days after irradation
Fia. 10. Changes in the number of
per unit area of sections from
sampled at intervals, after irrj
9, untreated; 0 15 Gy.
Days after
15 Gy
1
2
3
4
7
11
% Abnormal
mitoses + s.e.
47+3-3
33 + 16-7
83
80
30+ 15-3
20+5-8
Mean nuclear
diameter (gm)
15-1
17-0
13-7
14 16 18 ous in the perivascular tissue, and de-
creased in concentration with increasing
Ltage of distance from the vein. The proportion of
at inter- abnormal mitoses atintervals fromirradia-
h before tion (Table) decreased on Days 7 and 11;
however, this was chiefly the result of
dilution by an increase in the proportion
of 49-2 h of normal mitoses at this time.
h. Little variation in nuclear diameter was
r increased evident from comparison of means in
), possibly tumours sampled at 1, 7 or 11 days after
ained less 15 Gy; however, cells showed marked
Iropped to nuclear pleomorphism on Day 7 compared
covered to with Day 1, and this situation was largely
Lctivity of reversed by Day 11 (Fig. lIA and B).
les showed The degree of necrosis in both treated
hase peak- and untreated tumours progressed with
y (Fig. 8). increasing time from Day 0. The degree of
es (Fig. 9 haemorrhage present appeared to have no
pressed by correlation with treatment or time of
overed at evaluation. During Day 3 after treatment,
)re numer- lymphocytes and plasma cells accumu-
lated in the capsule surrounding the
T T tumour and superficial parenchymal in-
filtration of the tumour by lymphocytes ~-< 1 was noted. On Day 5 the lymphocytic in-
filtrate became more prominent, pene-
trating deeply into the parenchyma via
small lymphatic channels, and was asso-
ciated with focal cell necrosis. The lympho-
cytic infiltrate became less prominent on
Day 9, and by Day 11 only scattered
lymphocytes were noted in the paren-
chyma. Capsular lymphocytes and plasma
14 16 18 cells were in evidence throughout the
duration ofthis experiment (up to Day 17).
F mitoses DISCUSSION
tumours Both the labelling and mitotic indices adiation.
show that the rate of cell proliferation in
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(A) (B)
FIG. 11.-Sections ofirradiated tumours (15 Gy) H&E x 180. (A) Day 1-relative monorphism. (B) Day
7-increased pleomorphism.
tumour H-4-II-E was depressed for 7 days
after 15 Gy X-rays. The rate of clono-
genic cell proliferation was further de-
pressed, since a large proportion of the
mitotic figures scored over Days 0-7 were
abnormal and most probably represented
doomed cells (Table). After Day 7 the
rates of cell proliferation increased rapidly
to control levels, coinciding with increases
in [3H]-TdR incorporation and DNA con-
centration (a measure of tumour cellu-
larity), with the reinitiation of volume
growth at control rates and with the
fastest rate of increase in clonogenic cell
numbers. These data indicate that re-
population of the tumour with clonogenic
cells occurred mainly after Day 7 following
15 Gy ofX-rays.
The rate of increase in clonogenic cell
numbers (Fig. 6) suggests that cell pro-
liferation 7 days after 15 Gy is faster than
in untreated tumours. These data were
obtained by sequential sampling of indi-
vidual tumours from an irradiated popu-
lation, and thus give a valid indication of
post-irradiation changes only if tumour
sizes at treatment were similar. For the 36
tumours used in this experiment, maxi-
mum and minimum volumes at Day 0
were 1095 and 630 mm3 respectively, and
the mean + s.d. was 824-2 + 21-2 mm3. The
validity of the clonogenic assay itself is of
course questionable, and this is referred to
later.
The rate of [3H]-TdR incorporation into
DNA after irradiation (Fig. 8) is on Day 9
twice the value in age-equivalent controls
and also suggests rapid cell proliferation
at this time, presumably by a reduction in
the length of the S phase. Enhanced in-
corporation may also result from the
induction of partial synchrony.
The accelerated growth rate (Fig. iB)
parallels the increase in specific activity of
tumour DNA, but the time sequence is
delayed 3-4 days. Maximum labelling of
tumour DNA on Day 9 precedes the maxi-
mum rate of tumour growth by 4 days.
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Tumour DNA labelling and growth rates
are about twice the control values at the
time of their respective maxima. Studies
in patients with lung cancer have shown
that an accelerated increase in tumour
volume occurs 10-35 days after a reduc-
tion in tumour volume following single
and fractionated radiotherapy. Studies on
metastatic lung tumours from a variety of
primary cancers in the dog, on artificially
induced metastases in mice, and primary
rhabdomyosarcoma in the rat, showed a
similarly accelerated increase in tumour
volume after a reduction following treat-
ment (Van Peperzeel, 1972; Hermans &
Barendsen, 1978). Parallel studies in
another rat hepatoma line, 3924A, with
different growth, morphological and meta-
static characteristics have also shown
accelerated tumour growth after both
chemotherapy (i.e. cyclophosphamide) and
radiotherapy (Looney et al., 1980a).
Three other reports give evidence of
delays (other than mitotic delay) in the
proliferation of surviving cells after irradi-
ation. In the R-1 rhabdomyosarcoma,
20 Gy of X-rays reduced the clonogenic
fraction to 0-0027 and appeared to delay
proliferation of surviving cells for 4 days.
Six Gy of 15MeV neutrons reduced the
clonogenic fraction to 0 007 but delayed
surviving cell proliferation for 6 days,
producing an RBE for neutron-induced
growth delay of 3-3 but for cell killing 2-8.
Cell proliferation, once initiated, was at a
rate exceeding that in untreated tumours
(Barendsen & Broerse, 1969). In the
mouse carcinoma NT, Denekamp & Harris
(1976) used X-rays in a 2-dose assay for
tumour repopulation. Following 15 Gy an
increase in viable cells numbers was not
detected for 5 days. Finally, Szczepanski
& Trott (1975) monitored repopulation of
the C3H mouse adenocarcinoma 284 using
[3H]-TdR labelling. After 12 Gy of 300kV
X-rays, tumours regressed rapidly, but
for 4 days showed little change in growth
fraction or cell-cycle length. On Days 4-5
there was a transient and rapid increase in
the growth fraction, exceeding that of
controls, and apparently due to the
triggering of a cohort of quiescent (non-
cycling) cells into proliferation. The inter-
val between irradiation and the increase
in growth fraction was proportional to
dose, and suggested a "dose dependent
proliferative delay for resting tumour cells
forced to recycle". The authors rejected
the possibility that reoxygenation was the
factor initiating cell proliferation, since
earlier conditions appeared sufficient to
support proliferation.
From these reports and our own data it
is clear that tumour growth delay cannot
simply depend on the fraction of tumour
cells that have retained the capacity for
unlimited proliferation. Neither then can
we expect a linear relationship between
growth delay and log surviving fraction.
In fact, in the instances (of which we are
aware) where this has been determined
following irradiation (here; McNally, 1973;
Stephens & Steel, 1980), a linear relation-
ship was not observed.
McNally measured the surviving frac-
tions, assayed in vitro and the correspond-
ing growth-delays for tumour RIB5C
irradiated under 3 levels of oxygenation:
euoxic (animals breathing air), hyperoxic
(animals breathing 02) and hypoxic
(tumours clamped). Under euoxic con-
ditions of irradiation the increase in delay
with decrease in log surviving fraction was
less rapid above a surviving fraction of
10-1 than below. Under hyperoxic or
hypoxic conditions delay increased
linearly over the whole range, diverging
from the curve for euoxic irradiations
below a surviving fraction of 10-1. Thus,
for a reduction in surviving fraction to
less than 10-1, greatest growth delay was
measured in tumours of air-breathing
animals. McNally was unable to ascribe
these differences in OER for cell killing
and tumour growth delay to an in vivo
biological mechanism, but suggested in-
stead that there were an artefact of the
clonogenic assay. This possibility cannot
be eliminated; however, the existence of a
"dose dependent proliferative delay for
resting tumour cells forced to recycle"
(Szczepanski & Trott, 1975) provides an
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alternative, if speculative interpretation
of both our own and McNally's results,
assuming that RIB5C and H-4-11-E con-
tain a fraction of quiescent, radioresistant
cells. This is a reasonable assumption for
RIB5C, since McNally reports a 10%
hypoxic fraction and, as Tannock (1968,
1972) suggested, and Hermans & Barend-
sen (1978) demonstrated, these cells tendto
be both radioresistant and quiescent. The
existence of a quiescent cell population in
H-4-II-E has not been confirmed, although
all tumours examined contained cords
and, as already stated, mitotic cells were
more numerous in the perivascular tissue
and decreased in concentration with in-
creasing distance from the vein. On these
assumptions, the proportion of quiescent
and proliferative cells remaining to re-
populate the tumour after irradiation will
vary with dose. At low doses repopulation
will be effected by both proliferative and
quiescent cells and may be initiated im-
mediately after a period of mitotic delay.
High-dose treatment will leave only
quiescent (resting) cells viable, thus re-
population will proceed only after the
postulated period of proliferative delay.
The curve relating growth delay and log
surviving fraction would then be biphasic,
as observed. In fact the point of inflection
occurs at a surviving fraction of 10-1 in
RIB5C, below which, as McNally points
out, cell survival is indeed attributable to
the hypoxic fraction. Making the same
assumptions, the effect ofirradiation under
hyperoxic or hypoxic conditions will be to
reduce the selectivity of the treatment by
eliminating oxygen gradients within the
tumour. At all doses a fraction ofprolifera-
tive cells will remain viable and capable
of tumour repopulation at the expected
rate. McNally's data show that the Td Of
the surviving population was 3-3 days for
tumours of air-breathing animals and 1P5
days for tumours irradiated under ab-
normal oxygenation. Td for untreated
controls was 2-7 days.
A proliferative delay was discounted by
McNally because assays of the clonogenic
fraction of RIB5C at intervals from
irradiation showed that for similar cell
kills under the 3 irradiation conditions
(surviving fraction= 10-2), all returned to
a clonogenic fraction of 1 at the same
time. However, the surviving fraction
tells us only when dead (non-clonogenic)
cell clearance is completed, not when sur-
viving cell proliferation begins.
The time of repopulation after irradia-
tion may of course be determined by
factors other than a proliferative delay;
e.g. the degree of cell clearance or re-
oxygenation. In a C3H mouse mammary
tumour, changes in tumour cord radii and
cellularity indicated an initial cell clear-
ance during mitotic delay, then prolifera-
tion of sterilized cells, followed by clear-
ance of those cells to produce a minimum
of cellularity (and presumably increased
nutrient and oxygen supply) before re-
growth begins (Tannock & Howes, 1973).
It is quite possible that reoxygenation or
cell clearance is a factor in the recovery of
H-4-II-E. At 7 days, when tumour growth
resumed, the clonogenic fraction was a
little less than 40%. This is about the same
size as the clonogenic fraction (20%) in the
R-1 sarcoma at the beginning of recovery
after X-rays or neutrons (Barendsen &
Broerse, 1969). However, such an ex-
planation cannot by itself account for the
biphasic shape of the curve relating cell
survival and growth delay.
Vascular damage was the suggested
cause ofa chronic reduction in growth rate
in the mouse adenocarcinoma C3HBA
(Nelson et al., 1976) and of secondary
growth delay in the R-1 sarcoma
(Tenforde et al., 1979) and the fibro-
sarcoma RIB5 (Thomlinson & Craddock,
1967). Secondary growth delay is a period
ofslowed tumour growth that occurs after
the initial period of recovery and at a
volume similar to that at the time of
treatment.
The observations presented and cited
here have several implications: (a) They
demand a precise definition of the term
"repopulation". It is used here in refer-
ence to the proliferation of cells surviving
irradiation. It does not refer to changes in
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the proportions of clonogenic to non-
clonogenic cells, which may merely be a
function of dead-cell clearance and not a
result of clonogenic-cell proliferation.
Assays ofthe clonogenic fraction alone are
therefore inadequate to demonstrate the
time of repopulation. (b) Since growth
delay cannot be directly related to log cell
kill and because tumour cure is neces-
sarily dependent upon cell killing, growth
delay may be a misleading measure of
therapeutic effect; assuming ofcourse that
the object of therapy is cure and not
remission. (c) If the interpretation of
tumour cord dynamics is correct (Tannock,
1968) a proliferative delay as seen here
may reduce cell loss at the cord periphery
and perhaps from the tumour as a whole,
in which case the interpretation oftumour
volume changes after irradiation may
sometimes require revision. (d) The faster
growth rates in irradiated tumours than
in control tumours 10-16 days after treat-
ment offer the possibility ofincreasing the
effectiveness of sequential therapy by
giving radiation or proliferation-depend-
ent chemotherapy agents during this
period pf accelerated tumour growth.
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